Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,484 | -3,741 | -12,344 | -9,092 | -5,683 |
| Depreciation Amortization | 465 | 231 | 912 | 705 | 460 |
| Accounts receivable | -39 | 77 | -58 | -16 | -101 |
| Other Working Capital | -446 | -698 | 2,946 | -1,922 | -1,577 |
| Other Operating Activity | 94 | 242 | 1,501 | 1,376 | 1,025 |
| Operating Cash Flow | $-7,410 | $-3,890 | $-7,043 | $-8,948 | $-5,876 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,103 | 2,000 | N/A | -5,700 | -9,000 |
| PPE Investments | -76 | -63 | -47 | -95 | -37 |
| Purchase Of Investment | N/A | N/A | -24,000 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 9,300 | N/A | N/A |
| Purchase Sale Intangibles | -310 | -195 | -1,318 | -497 | -378 |
| Other Investing Activity | -310 | -195 | -1,319 | -497 | -378 |
| Investing Cash Flow | $-9,489 | $1,742 | $-16,065 | $-6,291 | $-9,416 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,284 | 79 | 14,326 | 121 | 75 |
| Dividend Paid | -23 | -15 | -132 | -131 | -99 |
| Other Financing Activity | 36 | 36 | 0 | 0 | 0 |
| Financing Cash Flow | $16,297 | $99 | $14,193 | $-10 | $-25 |
| Exchange Rate Effect | 66 | 60 | 70 | 23 | 23 |
| Beginning Cash Position | 8,322 | 8,322 | 17,167 | 17,167 | 17,167 |
| End Cash Position | 7,786 | 6,334 | 8,322 | 1,940 | 1,873 |
| Net Cash Flow | $-536 | $-1,988 | $-8,845 | $-15,227 | $-15,294 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,410 | -3,890 | -7,043 | -8,948 | -5,876 |
| Capital Expenditure | -76 | -63 | -47 | -95 | -37 |
| Free Cash Flow | -7,486 | -3,953 | -7,090 | -9,043 | -5,913 |